Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

David Wyles

Concepts (241)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antiviral Agents
59
2025
741
11.780
 Why?
Hepatitis C, Chronic
32
2025
163
9.340
 Why?
Hepacivirus
48
2025
259
8.630
 Why?
Hepatitis C
29
2025
265
8.300
 Why?
Benzimidazoles
16
2020
168
4.300
 Why?
Drug Resistance, Viral
18
2025
115
4.100
 Why?
Coinfection
15
2020
137
3.060
 Why?
HIV Infections
28
2022
2820
3.050
 Why?
Ribavirin
15
2020
91
2.370
 Why?
Sofosbuvir
16
2022
59
2.300
 Why?
Quinoxalines
7
2019
66
2.280
 Why?
Fluorenes
7
2020
42
2.250
 Why?
Sulfonamides
13
2020
512
2.250
 Why?
Viral Nonstructural Proteins
10
2025
65
2.180
 Why?
Liver Cirrhosis
8
2020
316
2.160
 Why?
Drug Therapy, Combination
26
2020
1063
1.830
 Why?
Uridine Monophosphate
5
2016
15
1.700
 Why?
Carbamates
9
2020
49
1.470
 Why?
Anti-Retroviral Agents
5
2019
232
1.450
 Why?
Protease Inhibitors
10
2020
106
1.390
 Why?
Hepatitis B, Chronic
3
2019
23
1.350
 Why?
Proline
11
2020
79
1.270
 Why?
Pyrrolidines
9
2019
80
1.210
 Why?
Genotype
21
2025
1923
1.200
 Why?
Congresses as Topic
3
2021
234
1.180
 Why?
Sustained Virologic Response
11
2025
40
1.160
 Why?
Hepatitis, Viral, Human
3
2021
25
1.160
 Why?
Cyclopropanes
11
2020
90
0.980
 Why?
Drug Users
2
2024
39
0.970
 Why?
Lactams, Macrocyclic
10
2020
49
0.910
 Why?
Heterocyclic Compounds, 4 or More Rings
3
2017
20
0.810
 Why?
HIV-1
8
2020
861
0.790
 Why?
Treatment Failure
6
2025
354
0.750
 Why?
Virus Replication
7
2012
484
0.740
 Why?
Disease Eradication
1
2020
4
0.700
 Why?
Organophosphonates
4
2011
92
0.690
 Why?
Homosexuality, Male
2
2021
184
0.680
 Why?
RNA, Viral
9
2025
654
0.670
 Why?
Humans
77
2025
137294
0.660
 Why?
Anti-HIV Agents
6
2020
772
0.650
 Why?
Valine
7
2020
82
0.640
 Why?
Nucleic Acid Synthesis Inhibitors
2
2015
16
0.560
 Why?
Imidazoles
2
2015
239
0.540
 Why?
Ritonavir
6
2020
73
0.540
 Why?
Middle Aged
32
2025
33310
0.540
 Why?
Darunavir
1
2017
18
0.530
 Why?
Aminoisobutyric Acids
5
2019
7
0.520
 Why?
Uracil
5
2020
31
0.510
 Why?
Antiretroviral Therapy, Highly Active
3
2015
270
0.500
 Why?
Male
41
2025
67560
0.490
 Why?
Leucine
5
2019
111
0.490
 Why?
Treatment Outcome
18
2023
10800
0.490
 Why?
Anilides
5
2020
73
0.490
 Why?
Education, Medical, Continuing
1
2016
128
0.470
 Why?
Adult
31
2025
37724
0.460
 Why?
Biomedical Research
1
2021
693
0.450
 Why?
Adenine
4
2020
267
0.450
 Why?
Female
39
2025
73052
0.440
 Why?
Oligopeptides
2
2013
272
0.440
 Why?
Viral Load
7
2020
464
0.430
 Why?
Pyridazines
1
2014
56
0.430
 Why?
2-Naphthylamine
5
2020
7
0.420
 Why?
Macrocyclic Compounds
3
2019
9
0.420
 Why?
Purines
1
2014
176
0.410
 Why?
Quinolines
1
2014
177
0.400
 Why?
Replicon
3
2009
14
0.400
 Why?
Liver
1
2021
1941
0.390
 Why?
Scavenger Receptors, Class B
1
2012
14
0.380
 Why?
Disease Management
1
2016
627
0.380
 Why?
Aged
17
2024
23851
0.350
 Why?
Mass Screening
4
2025
1268
0.350
 Why?
Retreatment
2
2021
72
0.340
 Why?
Drug Synergism
3
2008
383
0.330
 Why?
Acquired Immunodeficiency Syndrome
2
2020
232
0.300
 Why?
Dideoxynucleosides
2
2005
21
0.290
 Why?
Liver Diseases
2
2016
311
0.290
 Why?
Interferon-alpha
4
2013
198
0.280
 Why?
Cytokines
1
2015
2090
0.270
 Why?
Amino Acid Substitution
2
2018
309
0.260
 Why?
Cytosine
2
2009
49
0.260
 Why?
Global Health
2
2020
386
0.250
 Why?
Hepatitis B virus
2
2019
40
0.230
 Why?
HIV
2
2019
234
0.230
 Why?
Herpes Simplex
1
2005
95
0.230
 Why?
Hepatitis
1
2004
48
0.230
 Why?
Alanine
2
2021
151
0.210
 Why?
Prevalence
3
2019
2715
0.200
 Why?
Interferons
2
2015
202
0.200
 Why?
Mutation, Missense
3
2014
338
0.190
 Why?
Young Adult
10
2019
13163
0.190
 Why?
Interferon beta-1a
1
2021
12
0.190
 Why?
Hospitals
2
2024
689
0.190
 Why?
Hepatitis A
1
2021
26
0.180
 Why?
Feasibility Studies
1
2025
949
0.180
 Why?
Phylogeny
1
2025
900
0.180
 Why?
Adenosine Monophosphate
1
2021
66
0.180
 Why?
Tenofovir
2
2020
240
0.180
 Why?
Hepatitis B
1
2021
70
0.170
 Why?
World Health Organization
1
2020
123
0.170
 Why?
Disease Progression
2
2019
2752
0.160
 Why?
Data Interpretation, Statistical
2
2018
363
0.160
 Why?
Polyethylene Glycols
2
2015
640
0.150
 Why?
Emergency Service, Hospital
3
2025
2054
0.150
 Why?
Esters
2
2009
76
0.150
 Why?
United States
10
2025
14742
0.150
 Why?
CD4 Lymphocyte Count
2
2017
268
0.150
 Why?
Ribosomes
2
2010
186
0.150
 Why?
Immunologic Factors
1
2020
237
0.150
 Why?
Nucleic Acid Conformation
4
2014
730
0.140
 Why?
Hospitalization
2
2024
2214
0.140
 Why?
Alanine Transaminase
1
2018
157
0.130
 Why?
DNA, Viral
1
2019
363
0.130
 Why?
Genes, Viral
1
2016
88
0.130
 Why?
DNA Mutational Analysis
1
2018
400
0.130
 Why?
Molecular Structure
2
2008
498
0.120
 Why?
Mutation
2
2018
3956
0.120
 Why?
Patient Compliance
1
2020
577
0.120
 Why?
Survival Analysis
1
2019
1321
0.120
 Why?
High-Throughput Nucleotide Sequencing
2
2016
537
0.120
 Why?
Adolescent
5
2022
21499
0.120
 Why?
Dose-Response Relationship, Drug
2
2017
2052
0.120
 Why?
Regulatory Sequences, Ribonucleic Acid
1
2014
19
0.110
 Why?
AIDS-Related Opportunistic Infections
1
2015
126
0.110
 Why?
Opiate Substitution Treatment
1
2016
147
0.110
 Why?
Chemokines
1
2015
228
0.110
 Why?
Risk Assessment
2
2025
3439
0.110
 Why?
Chemokine CXCL10
1
2014
39
0.110
 Why?
Drug Interactions
1
2015
406
0.110
 Why?
Phenylenediamines
1
2013
10
0.110
 Why?
Prospective Studies
5
2025
7595
0.110
 Why?
Fibrosis
1
2016
552
0.100
 Why?
Viral Proteins
2
2014
343
0.100
 Why?
Prognosis
2
2019
4026
0.100
 Why?
Microbial Sensitivity Tests
2
2012
359
0.100
 Why?
Drug Combinations
3
2019
344
0.100
 Why?
Quality of Life
1
2025
2885
0.100
 Why?
Drug Discovery
1
2013
141
0.090
 Why?
Administration, Oral
1
2014
812
0.090
 Why?
Mental Disorders
1
2020
1077
0.090
 Why?
Cohort Studies
5
2024
5726
0.090
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2013
251
0.090
 Why?
Case-Control Studies
2
2017
3546
0.090
 Why?
Telemedicine
1
2020
854
0.090
 Why?
Models, Molecular
3
2012
1594
0.090
 Why?
Prodrugs
1
2011
52
0.090
 Why?
Nucleosides
1
2010
27
0.090
 Why?
Riboswitch
1
2012
67
0.080
 Why?
Japan
2
2021
116
0.080
 Why?
Drug Administration Schedule
3
2017
786
0.080
 Why?
Cell Line, Tumor
2
2008
3414
0.080
 Why?
Drug Design
1
2010
167
0.080
 Why?
Biomarkers
1
2020
4164
0.080
 Why?
Cell Line
2
2012
2841
0.080
 Why?
Piperidines
1
2010
206
0.070
 Why?
Phenylthiourea
1
2008
5
0.070
 Why?
Practice Guidelines as Topic
1
2016
1577
0.070
 Why?
Body Mass Index
1
2017
2373
0.070
 Why?
Immunity, Innate
1
2014
827
0.070
 Why?
Plasmids
1
2009
362
0.070
 Why?
Structure-Activity Relationship
1
2009
574
0.070
 Why?
Inhibitory Concentration 50
1
2006
90
0.070
 Why?
Luciferases
1
2006
150
0.060
 Why?
Genes, Reporter
1
2006
269
0.060
 Why?
Thailand
1
2025
17
0.060
 Why?
Saquinavir
1
2004
1
0.060
 Why?
Simplexvirus
1
2005
80
0.060
 Why?
Indinavir
1
2004
7
0.060
 Why?
Uganda
1
2025
73
0.060
 Why?
Nelfinavir
1
2004
9
0.060
 Why?
Drug Labeling
1
2005
40
0.060
 Why?
Nevirapine
1
2004
17
0.060
 Why?
Oxazines
1
2004
30
0.060
 Why?
Pandemics
2
2024
1623
0.060
 Why?
Benzoxazines
1
2004
31
0.060
 Why?
Lopinavir
1
2004
30
0.060
 Why?
Brazil
1
2025
167
0.060
 Why?
Alkynes
1
2004
56
0.060
 Why?
Zidovudine
1
2004
78
0.060
 Why?
Time Factors
1
2015
6818
0.060
 Why?
Liver Function Tests
1
2004
114
0.060
 Why?
Reverse Transcriptase Inhibitors
1
2004
84
0.060
 Why?
Transfection
1
2006
947
0.060
 Why?
South Africa
1
2025
219
0.060
 Why?
Pregnancy
1
2017
6743
0.050
 Why?
Bone Marrow Transplantation
1
2005
287
0.050
 Why?
Pyrimidinones
1
2004
113
0.050
 Why?
Recombinant Fusion Proteins
1
2006
664
0.050
 Why?
Carcinoma, Hepatocellular
1
2006
361
0.050
 Why?
Double-Blind Method
2
2021
1985
0.050
 Why?
Polyphosphates
1
2022
36
0.050
 Why?
Singapore
1
2021
22
0.050
 Why?
Republic of Korea
1
2021
36
0.050
 Why?
Dried Blood Spot Testing
1
2022
103
0.050
 Why?
Mexico
1
2021
225
0.040
 Why?
Retrospective Studies
5
2019
15639
0.040
 Why?
Protein Biosynthesis
2
2014
434
0.040
 Why?
Liver Neoplasms
1
2006
785
0.040
 Why?
Raltegravir Potassium
1
2019
17
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2019
75
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2019
105
0.040
 Why?
Intensive Care Units
1
2024
802
0.040
 Why?
Drug Resistance, Multiple, Viral
1
2017
10
0.030
 Why?
Longitudinal Studies
1
2024
2850
0.030
 Why?
Kinetics
1
2020
1674
0.030
 Why?
Oxygen
1
2021
935
0.030
 Why?
Medicaid
1
2020
434
0.030
 Why?
Program Evaluation
1
2020
891
0.030
 Why?
Incidence
2
2013
2808
0.030
 Why?
RNA
1
2022
924
0.030
 Why?
Cell-Free System
1
2014
53
0.030
 Why?
Hepatitis C Antibodies
1
2014
11
0.030
 Why?
Spain
1
2014
41
0.030
 Why?
Enzyme-Linked Immunosorbent Assay
1
2016
851
0.030
 Why?
Polymorphism, Genetic
1
2017
658
0.030
 Why?
Patient Acceptance of Health Care
1
2020
808
0.030
 Why?
Patient Care
1
2014
110
0.030
 Why?
Aged, 80 and over
2
2019
7607
0.030
 Why?
Patient Reported Outcome Measures
1
2017
406
0.030
 Why?
Withholding Treatment
1
2013
77
0.030
 Why?
Risk Factors
2
2020
10368
0.030
 Why?
Early Diagnosis
1
2014
244
0.030
 Why?
Plasma
1
2014
213
0.020
 Why?
Fluorescence Resonance Energy Transfer
1
2012
177
0.020
 Why?
Virus Internalization
1
2010
49
0.020
 Why?
Ligands
1
2012
664
0.020
 Why?
Recombinant Proteins
1
2013
1354
0.020
 Why?
Pilot Projects
1
2015
1700
0.020
 Why?
Magnesium
1
2009
158
0.020
 Why?
Lamivudine
1
2009
63
0.020
 Why?
Genome, Viral
1
2009
145
0.020
 Why?
Referral and Consultation
1
2014
778
0.020
 Why?
Logistic Models
1
2013
2071
0.020
 Why?
Phenotype
1
2014
3202
0.020
 Why?
Base Sequence
1
2009
2182
0.020
 Why?
Severity of Illness Index
1
2013
2836
0.020
 Why?
Randomized Controlled Trials as Topic
1
2011
1464
0.010
 Why?
Mice, Transgenic
1
2009
2164
0.010
 Why?
Animals
2
2018
36862
0.010
 Why?
Substance-Related Disorders
1
2011
1073
0.010
 Why?
Signal Transduction
1
2009
5078
0.010
 Why?
Mice
1
2009
17774
0.010
 Why?
Wyles's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (241) concept(s)
_
Co-Authors Expand Description
See all (18) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)